AstraZeneca PLC engages in the discovery, development, manufacture, and commercialization of prescription medicines for the treatment of oncology, cardiovascular and metabolic, respiratory, infection, gastrointestinal, and neuroscience diseases worldwide. Its marketed products comprise Arimidex, Casodex/Cosudex, Faslodex, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Imdur, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Symlin, Xigduo, and Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Eklira Genuair/Tudorza Pressair, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, and Symbicort Turbuhaler for respiratory diseases; Fluenz Tetra/FluMist Quadrivalent and Synagis for infection diseases; Movantik/Moventig, Seroquel IR, Seroquel XR, Vimovo1, and Zomig for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. It serves primary care and specialty care physicians through distributors and local representative offices. The company's pipeline includes 132 projects, of which 120 are in the clinical phase of development. It has collaboration agreements with Valeant Holdings Ireland, and Eli Lilly and Company; definitive agreement with Foundation Medicine, Inc.; strategic collaboration with FibroGen and Astellas; collaboration and license agreement with Celgene International Sarl; and license agreement with LEO Pharma A/S. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
$ 10.771 B
Cost of Revenue
$ 2.998 B
$ 7.773 B
$ 417.000 M
-$ 0.42 (-0.63%)
Last updated on Wed 22nd Mar 2023 08:00:01 IST
52 Week High
52 Week Low
$ 206.343 B
|Stock Name||Stock Price||52 Week High||52 Week Low||Capital|
|$ 82.51||$ 90.33||$ 71.00||Large Cap|
|$ 66.98||$ 80.80||$ 64.94||Large Cap|
|$ 97.04||$ 122.66||$ 92.83||Large Cap|
|$ 155.56||$ 181.77||$ 151.23||Large Cap|
|$ 332.64||$ 383.20||$ 273.35||Large Cap|
|$ 40.18||$ 54.46||$ 39.23||Large Cap|
|$ 261.22||$ 311.88||$ 187.16||Large Cap|
|$ 48.79||$ 56.20||$ 36.91||Large Cap|
|$ 104.23||$ 114.69||$ 77.39||Large Cap|
|$ 35.22||$ 56.49||$ 27.92||Large Cap|
Frequently Asked Questions
What is the price of AstraZeneca PLC share today in India?
What was the highest AstraZeneca PLC share stock price?
What is the lowest price of AZN shares?
How to buy AZN shares in India?
Is AstraZeneca PLC shares Listed on NSE or BSE?
Can I buy AstraZeneca PLC shares in India?
Can I buy fractional shares of AstraZeneca PLC?
What is the P/E ratio for AstraZeneca PLC shares?
What is the traded volume of AstraZeneca PLC shares?
What is the market capitalization of AstraZeneca PLC shares?